David Bomze

3.4k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

David Bomze is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, David Bomze has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Infectious Diseases. Recurrent topics in David Bomze's work include Cancer Immunotherapy and Biomarkers (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). David Bomze is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). David Bomze collaborates with scholars based in Israel, Switzerland and United States. David Bomze's co-authors include Lukas Flatz, Omar Hasan Ali, Yaakov Nahmias, Tomer Meirson, Gahl Levy, Merav Cohen, Daniel Kitsberg, Gal Markel, Eran Meshorer and Dinorah Barasch and has published in prestigious journals such as Blood, Nature Biotechnology and Bioinformatics.

In The Last Decade

David Bomze

41 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells

2015 518 citations Arieh Moussaieff, Matthieu Rouleau et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Bomze Israel	22	711	608	332	183	173	42	1.8k
Xiaomei Zhang China	16	706 1.0×	768 1.3×	631 1.9×	268 1.5×	349 2.0×	36	1.9k
Francesco Sabbatino Italy	23	594 0.8×	992 1.6×	479 1.4×	278 1.5×	249 1.4×	96	1.9k
Mhairi Copland United Kingdom	35	1.5k 2.2×	681 1.1×	358 1.1×	139 0.8×	274 1.6×	131	4.3k
Andreas S. Barth United States	31	1.3k 1.8×	686 1.1×	353 1.1×	176 1.0×	225 1.3×	81	3.0k
Duojiao Wu China	24	839 1.2×	405 0.7×	561 1.7×	208 1.1×	406 2.3×	70	1.8k
Muhammad Furqan United States	20	800 1.1×	814 1.3×	259 0.8×	285 1.6×	206 1.2×	114	1.8k
Rui Qiao China	20	805 1.1×	563 0.9×	163 0.5×	195 1.1×	244 1.4×	56	1.6k
Jiang Liu United States	16	426 0.6×	446 0.7×	227 0.7×	149 0.8×	117 0.7×	43	1.5k
Afshin Derakhshani Iran	26	764 1.1×	812 1.3×	655 2.0×	223 1.2×	424 2.5×	70	2.0k

Countries citing papers authored by David Bomze

Since Specialization

Citations

This map shows the geographic impact of David Bomze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bomze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bomze more than expected).

Fields of papers citing papers by David Bomze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bomze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bomze. The network helps show where David Bomze may publish in the future.

Co-authorship network of co-authors of David Bomze

This figure shows the co-authorship network connecting the top 25 collaborators of David Bomze. A scholar is included among the top collaborators of David Bomze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bomze. David Bomze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bareket‐Samish, Avital, Daniel A. Goldstein, Eli Rosenbaum, et al.. (2025). Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses. International Journal of Radiation Oncology*Biology*Physics. 122(2). 224–233.

Youngster, Ilan, Ivetta Danylesko, Israel Henig, et al.. (2024). Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study. Bone Marrow Transplantation. 59(3). 409–416. 7 indexed citations

Saiag, Esther, Ronni Gamzu, Hagit Padova, et al.. (2024). Antibody Response After a Fifth Dose (Third Booster) of BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers. Journal of Clinical Medicine. 13(21). 6538–6538. 1 indexed citations

Meirson, Tomer, David Bomze, Ora Schueler‐Furman, Salomon M. Stemmer, & Gal Markel. (2023). Systemic structural analysis of alterations reveals a common structural basis of driver mutations in cancer. NAR Cancer. 5(1). zcac040–zcac040. 1 indexed citations

Bomze, David, Janan Mohamad, N. Malchin, et al.. (2023). Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa. Pediatric Dermatology. 40(6). 1021–1027. 1 indexed citations

Kedmi, Meirav, Roni Shouval, Shalev Fried, et al.. (2022). Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma. Transplantation and Cellular Therapy. 28(5). 251–257. 24 indexed citations

Saiag, Esther, Ayelet Grupper, Irit Avivi, et al.. (2022). The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients. Clinical Microbiology and Infection. 28(5). 735.e5–735.e8. 15 indexed citations

Horesh, Nir, David Bomze, Chétana Lim, et al.. (2022). Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect. HepatoBiliary Surgery and Nutrition. 11(6). 861–869. 2 indexed citations

Bomze, David, Eli Sprecher, Ilan Goldberg, Liat Samuelov, & Shamir Geller. (2021). Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study. Clinical Lymphoma Myeloma & Leukemia. 21(12). e1000–e1005. 8 indexed citations

10.

Goldman, Adam, Elad Maor, David Bomze, et al.. (2021). Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. Journal of the American College of Cardiology. 78(18). 1800–1813. 95 indexed citations

11.

Meirson, Tomer, David Bomze, & Gal Markel. (2020). Structural basis of SARS-CoV-2 spike protein induced by ACE2. Bioinformatics. 37(7). 929–936. 21 indexed citations

12.

Ali, Omar Hasan, David Bomze, Lorenz Risch, et al.. (2020). Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clinical Infectious Diseases. 73(9). e2869–e2874. 69 indexed citations

13.

Shouval, Roni, Myriam Labopin, David Bomze, et al.. (2020). Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission. Bone Marrow Transplantation. 55(12). 2244–2253. 6 indexed citations

14.

Goldman, Adam, David Bomze, Rachel Dankner, et al.. (2020). Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports. British Journal of Clinical Pharmacology. 87(3). 1432–1442. 42 indexed citations

15.

Ali, Omar Hasan, Andrey A. Yurchenko, Olga Pavlova, et al.. (2020). Genomic profiling of late‐onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome. Journal of the European Academy of Dermatology and Venereology. 35(2). 396–402. 2 indexed citations

16.

Bomze, David, Tomer Meirson, Omar Hasan Ali, et al.. (2020). Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis. Ocular Immunology and Inflammation. 30(1). 191–197. 39 indexed citations

17.

Meirson, Tomer, Nethanel Asher, David Bomze, & Gal Markel. (2020). Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation. Cancers. 12(6). 1650–1650. 24 indexed citations

18.

Ali, Omar Hasan, David Bomze, Sandra S. Ring, et al.. (2019). BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology. 82(4). 854–861. 76 indexed citations

19.

Ali, Omar Hasan, Fiamma Berner, David Bomze, et al.. (2018). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer. 107. 8–14. 143 indexed citations

20.

Moussaieff, Arieh, Matthieu Rouleau, Daniel Kitsberg, et al.. (2015). Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells. Cell Metabolism. 21(3). 392–402. 518 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact